Withaferin A inhibits adipogenesis in 3T3-F442A cell line, improves insulin sensitivity and promotes weight loss in high fat diet-induced obese mice

The increased prevalence of obesity and associated insulin resistance calls for effective therapeutic treatment of metabolic diseases. The current PPARγ-targeting antidiabetic drugs have undesirable side effects. The present study investigated the anti-diabetic and anti-obesity effects of withaferin...

Descripción completa

Detalles Bibliográficos
Autores principales: Khalilpourfarshbafi, Manizheh, Devi Murugan, Dharmani, Abdul Sattar, Munavvar Zubaid, Sucedaram, Yamuna, Abdullah, Nor Azizan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6588247/
https://www.ncbi.nlm.nih.gov/pubmed/31226166
http://dx.doi.org/10.1371/journal.pone.0218792

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6588247/
https://www.ncbi.nlm.nih.gov/pubmed/31226166
http://dx.doi.org/10.1371/journal.pone.0218792

Ejemplares similares